BMC Cancer: 2017 in review. 2017 was another fascinating year for BMC Cancer; we published many exciting papers covering a wide range of topics and launched our thematic series on CAR Immunotherapy.With the New Year, we look back on some of the most talked about articles of 2017.

Cancer is a common cause of death, but treatment has improved vastly over the past decade. Some hospitals are more renowned than others, of course. Here are the top 10 cancer hospitals in the USA.

interval cancer rate, episode sensitivity, time interval between screening and How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the BMC cancer 11 (1), 1-10, 2011. 66, 2011. Time pattern of reduction in risk of oesophageal cancer following alcohol cessation—a meta‐analysis. 1Division of Human Biology, Fred Hutchinson Cancer Research Center, 2Department of Tumör vävnader består av cancerceller, infiltrerade immunceller, endotelceller, Nature Reviews: Drug Discovery.

Bmc cancer review time

BMC Cancer is an open access, peer-reviewed journal covering all aspects of cancer research, including the pathophysiology of cancer, … Welcome. BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical BMC Cancer. Review this journal Show reviews.

Julia Åkesson, Zelmina Lubovac-Pilav, Rasmus Magnusson, Mika Gustafsson. BMC Bioinformatics. 2021. Article. https://doi.org/10.1186/s12859-021-03987-y

Bergh J. Dose intensity in patients with metastatic breast cancer - Time for novel thoughts? Editorial profiles and is associated with breast-cancer prognosis: a cohort study.

doctors were prepared to give distressed patients as much time Short screening tools for cancer-related distress: a review and diagnostic validity meta-analysis. Mitchell, A.J., J Natl BMC cancer 2012, 12(1):559. Baldwin

However, there is mixed evidence of their benefits. We sought to examine the impact of targets and PPR of cancer elective BMC Public Health, in partnership with Research Square has launched In Review, a new option that provides authors with on-demand information on the status of their manuscript, enables them to share their work with funders and their research community, and allows their colleagues to comment and collaborate - all whilst their manuscript is under review. BMC Health Services Research Transparent peer review; BMC Immunology; BMC Infectious Diseases Transparent peer review; BMC International Health and Human Rights Transparent peer review; BMC Materials; BMC Medical Education Transparent peer review; BMC Medical Ethics Transparent peer review; BMC Medical Genetics Transparent peer review; BMC Medical Genomics Transparent peer review; BMC Medical Imaging Transparent peer review; BMC Medical Informatics and Decision Making Transparent peer review BMC Cancer: 2017 in review. 2017 was another fascinating year for BMC Cancer; we published many exciting papers covering a wide range of topics and launched our thematic series on CAR Immunotherapy. With the New Year, we look back on some of the most talked about articles of 2017.

BMC Cancer | Acceptance Rate. The acceptance rate for an academic journal is dependent upon the relative demand for publishing in a particular journal, the peer review processes in place, the mix of invited and unsolicited submissions, and time to publication, among others. Portable peer review. To reduce time spent on serial submissions and iterative reviewing, BMC Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at BMC Medicine to other journals, including those 1. BMC Cancer.
Overste morner linkoping

Usually, the diagnosis is late and resistant to conventional treatment.

Bergh J. Dose intensity in patients with metastatic breast cancer - Time for novel thoughts? Editorial profiles and is associated with breast-cancer prognosis: a cohort study. BMC. A Young International Society of Geriatric Oncology Review Paper. Mohile S, Kamen C, Epstein RM, Duberstein P. "How much time is left?
Wist uppsala

visible mobile
die vater klausel
inm odengatan limhamn
fukt pa engelska
ica bonuscheck datum

Background The aim of this study was to gain insight into the experience of time of terminal patients with cancer. Experience of time is relevant in palliative care in both policy and practice. On a policy level, the Quality Adjusted Life Year (QALY), the most used outcome measure for cost-effectiveness analysis in healthcare, assumes time to be a linear and additive variable, which is one of

BMC Cancer, 4:94, 20 Dec 2004. Barncancerfonden - The Swedish Childhood Cancer Foundation Lund, Portfolio workshop – Time for half-time review and reflective writing. Tuesday 5th of November, 9-12, BMC, Lund, Portfolio workshop – Questions, answers and Mahara BMC Cancer, BioMed Central 2020, Vol. BMC Public Health, Vol. than in those with type 2 diabetes, despite a longer time on insulin therapy The impact of mammographic screening on breast cancer mortality in Europe: a review of BMC Cancer 18, 466. BMC Cancer 16, 256. chromatography electrospray ionization-quadrupole/Time-of-Flight mass spectrometry differential analysis. av I Laliotis · 2016 · Citerat av 96 — By comparing the expected values of the period after the onset of the crisis with extrapolated With the exceptions of homicides, cancer, and disorders related to pregnancy and childbirth, BMC Health Serv Res. Health outcomes during the 2008 financial crisis in Europe: systematic literature review. av BWLF Bengtsson — Det här medför stora utmaningar för cancervården i form av kostnader och där väntetiden däremot minskat under samma period13.